JP2016531108A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531108A5
JP2016531108A5 JP2016528587A JP2016528587A JP2016531108A5 JP 2016531108 A5 JP2016531108 A5 JP 2016531108A5 JP 2016528587 A JP2016528587 A JP 2016528587A JP 2016528587 A JP2016528587 A JP 2016528587A JP 2016531108 A5 JP2016531108 A5 JP 2016531108A5
Authority
JP
Japan
Prior art keywords
group
branched
linear
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016528587A
Other languages
English (en)
Japanese (ja)
Other versions
JP6458028B2 (ja
JP2016531108A (ja
Filing date
Publication date
Priority claimed from FR1357277A external-priority patent/FR3008978A1/fr
Application filed filed Critical
Publication of JP2016531108A publication Critical patent/JP2016531108A/ja
Publication of JP2016531108A5 publication Critical patent/JP2016531108A5/ja
Application granted granted Critical
Publication of JP6458028B2 publication Critical patent/JP6458028B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016528587A 2013-07-23 2014-07-22 インドール及びピロールの新規な誘導体、その製造方法及びそれを含む医薬組成物 Expired - Fee Related JP6458028B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1357277A FR3008978A1 (fr) 2013-07-23 2013-07-23 "nouveaux derives d'indole et de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
FR13/57277 2013-07-23
PCT/FR2014/051884 WO2015011396A1 (fr) 2013-07-23 2014-07-22 Nouveaux derives d'indole et de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
JP2016531108A JP2016531108A (ja) 2016-10-06
JP2016531108A5 true JP2016531108A5 (https=) 2017-08-24
JP6458028B2 JP6458028B2 (ja) 2019-01-23

Family

ID=49911607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016528587A Expired - Fee Related JP6458028B2 (ja) 2013-07-23 2014-07-22 インドール及びピロールの新規な誘導体、その製造方法及びそれを含む医薬組成物

Country Status (31)

Country Link
US (2) US9765056B2 (https=)
EP (2) EP3168217A1 (https=)
JP (1) JP6458028B2 (https=)
KR (1) KR102337149B1 (https=)
CN (1) CN105408321B (https=)
AR (1) AR099914A1 (https=)
AU (1) AU2014294866B2 (https=)
BR (1) BR112016001333B1 (https=)
CA (1) CA2917965C (https=)
CY (1) CY1120475T1 (https=)
DK (1) DK3027602T3 (https=)
EA (1) EA028609B1 (https=)
ES (1) ES2687475T3 (https=)
FR (1) FR3008978A1 (https=)
HK (1) HK1218753A1 (https=)
HR (1) HRP20181333T1 (https=)
HU (1) HUE039507T2 (https=)
LT (1) LT3027602T (https=)
MX (1) MX364479B (https=)
NZ (1) NZ715847A (https=)
PL (1) PL3027602T3 (https=)
PT (1) PT3027602T (https=)
RS (1) RS57545B1 (https=)
RU (1) RU2693404C2 (https=)
SG (1) SG11201600004SA (https=)
SI (1) SI3027602T1 (https=)
TW (1) TW201504224A (https=)
UA (1) UA117020C2 (https=)
UY (1) UY35653A (https=)
WO (1) WO2015011396A1 (https=)
ZA (1) ZA201600415B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105237509A (zh) * 2015-11-20 2016-01-13 江苏瑞邦农药厂有限公司 一种2,2-二氟-1,3-苯并二恶茂的合成方法
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454862B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
EP4491236A3 (en) 2016-05-10 2025-04-02 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
CN116462666B (zh) 2017-01-10 2025-07-15 瑞士苏黎世联邦理工学院 细胞保护性化合物及其用途
EP3604540A4 (en) 2017-03-31 2020-12-23 The University of Tokyo NOROVIRUS ANTIBODIES
EP4717317A2 (en) 2017-06-20 2026-04-01 C4 Therapeutics, Inc. N/o-linked degrons and degronimers for protein degradation
CN108409580A (zh) * 2018-02-01 2018-08-17 浙江工业大学 一种苄胺类化合物的合成方法
CN120698983A (zh) 2018-12-20 2025-09-26 C4医药公司 靶向蛋白降解
CN120787162A (zh) 2022-05-20 2025-10-14 诺华股份有限公司 抗肿瘤化合物的抗体-药物缀合物及其使用方法
PY24103486A (es) 2023-11-22 2025-06-06 Servier Lab Conjugados de anticuerpo anti-cd74-fármaco y métodos de uso de los mismos
TW202540186A (zh) 2023-11-22 2025-10-16 瑞士商諾華公司 抗cd7抗體藥物結合物及其使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2298832T3 (es) 2003-10-24 2008-05-16 Glaxo Group Limited Compuestos heterociclicos.
TW200533398A (en) * 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
CA2577752A1 (en) * 2004-08-20 2006-03-02 The Regents Of The University Of Michigan Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
GB0522908D0 (en) 2005-11-10 2005-12-21 Merck Sharp & Dohme Therapeutic agents
CN103732589B (zh) * 2011-05-25 2016-03-30 百时美施贵宝公司 可用作抗细胞凋亡bcl抑制剂的取代的磺酰胺
EP2794588A1 (en) * 2011-12-23 2014-10-29 Novartis AG Compounds for inhibiting the interaction of bcl2 with binding partners
EP2794592A1 (en) * 2011-12-23 2014-10-29 Novartis AG Compounds for inhibiting the interaction of bcl2 with binding partners
JP2015503518A (ja) * 2011-12-23 2015-02-02 ノバルティス アーゲー Bcl2と結合相手の相互作用を阻害するための化合物
BR112014015442A8 (pt) * 2011-12-23 2017-07-04 Novartis Ag compostos e composições para inibir a interação de bcl2 com parceiros de ligação
MX2014007732A (es) * 2011-12-23 2015-01-12 Novartis Ag Compuestos para inhibir la interaccion de bcl2 con los mismos componentes de enlace.
FR2986002B1 (fr) * 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Similar Documents

Publication Publication Date Title
JP2016531108A5 (https=)
RU2016106002A (ru) Новые индольные и пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их
RU2014130125A (ru) Новые пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их
RU2478636C2 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДИН-2-ОНА, ОБЛАДАЮЩИЕ mTOR ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ
KR20250029954A (ko) 피리도[4,3-d]피리미딘 화합물
RU2016105999A (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
JP5581390B2 (ja) Akt阻害剤
TWI795362B (zh) 拮抗藥與免疫核查點阻礙藥而成之組合
RU2014130129A (ru) Новые фосфатные соединения, способ их получения и фармацевтические композиции, содержащие их
RU2016106003A (ru) Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их
TW201808888A (zh) 整合應激途徑之調節劑
JP2021501788A (ja) 統合的ストレス経路の調節剤
RU2014134388A (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
JP2010531344A5 (https=)
KR20150127194A (ko) 키누레닌 경로의 억제제
JP2016525529A5 (https=)
CN105732637B (zh) 杂芳化合物及其在药物中的应用
BR112021005896A2 (pt) moduladores da monoacilglicerol lipase
JP2013520443A5 (https=)
JP6276865B2 (ja) アリールラクタムキナーゼ阻害剤
US12006320B2 (en) Heterocyclic derivatives as PI3K inhibitors
JP2015528018A (ja) アリールラクタムキナーゼ阻害剤
KR20250100539A (ko) 피리도[4,3-d]피리미딘 화합물
ES2991283T3 (es) Derivado de 6,7-dihidropirazolo[1,5-a]pirazinona y aplicación médica del mismo